These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6541358

  • 1. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF.
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [Abstract] [Full Text] [Related]

  • 2. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A, Keith AB, Wright C, Edwardson JA.
    Neurosci Lett; 1982 Jan 22; 28(1):87-92. PubMed ID: 7063145
    [Abstract] [Full Text] [Related]

  • 3. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS.
    Neuropharmacology; 1988 Sep 22; 27(9):903-7. PubMed ID: 3185866
    [Abstract] [Full Text] [Related]

  • 4. Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats.
    Buwalda B, Nyakas C, Koolhaas JM, Bohus B.
    Physiol Behav; 1991 Nov 22; 50(5):929-32. PubMed ID: 1805283
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R, Diamant M, de Jong W, de Wied D.
    Physiol Behav; 1992 Mar 22; 51(3):507-13. PubMed ID: 1326112
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of vasopressin and analogue [d(CH2)1(5), Tyr (Me)2, Val4, delta 3Pro7)] AVP on learning and memory in rats chronically treated with ethanol.
    Car H, Borawska MH, Wiśniewski K.
    J Physiol Pharmacol; 1994 Mar 22; 45(1):163-71. PubMed ID: 8043905
    [Abstract] [Full Text] [Related]

  • 15. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
    Tanabe S, Shishido Y, Furushiro M, Kado K, Hashimoto S, Yokokura T, Ohsawa T.
    Pharmacol Biochem Behav; 1997 Mar 22; 57(1-2):251-6. PubMed ID: 9164579
    [Abstract] [Full Text] [Related]

  • 16. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
    Kovács GL, Bohus B, Versteeg DH, de Kloet ER, de Wied D.
    Brain Res; 1979 Oct 19; 175(2):303-14. PubMed ID: 487159
    [Abstract] [Full Text] [Related]

  • 17. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G, Itoh S.
    Peptides; 1986 Oct 19; 7(1):105-10. PubMed ID: 3714527
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM.
    J Pharmacol Exp Ther; 1987 Apr 19; 241(1):268-74. PubMed ID: 3572787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.